ARCHIVES

Tamoxifin Benefits Outweigh Risks, NSABP Study Finds

This article is from The Cancer Letter archive.

Vol. 20 No. 12 | March 23, 1994

Download PDF Visit The Full Archive

Related Articles

Leter: Payers Must Determine Appropriate Therapies

July 19, 1996

Interview: “People don’t understand Clinical Trials.

September 5, 1997

Interview With Departing NCI Director; Advice To His Successor.

July 9, 2010

CTEP Drafts FDA Approval Guidelines

March 4, 1988

Organizations Ask Senate To Increase NCI Appropriations, Order OMB To “Get Nose Out Of Tent”

May 2, 1986

In Brief: appropriations Approved; Grants, contracts May Flow Unimpeded; NCI Positions An Issue

December 16, 1977